| [1] American Cancer Society. Cancer Facts & Figures 2012. Atlanta: American Cancer Society, 2012.[2] Maddalena B, Armando F, Massimo R, Salvatore G, Walter M, Malorni GP. Reducing the risk of overdiagnosis in lung cancer: A support from molecular biology. Cell Physiol, 2011, 226(9): 2213-2214.[3] Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y, Chen Y, Xu L, Zen K, Zhang C, Shen H. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol, 2010, 28(10): 1721-1726.[4] Ferracin M, Veronese A, Negrini M. Micromarkers: miRNAs in cancer diagnosis and prognosis. Expert Rev Mol Diagn, 2010, 10(3): 297-308.[5] Cortez MA, Calin GA. MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin Biol Ther, 2009, 9(6): 703-711.[6] Wang QZ, Xu W, Habib N, Xu R. Potential uses of mi-croRNA in lung cancer diagnosis, prognosis, and therapy. Curr Cancer Drug Targets, 2009, 9(4): 572-594.[7] Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, Galas DJ, Wang K. The microRNA spectrum in 12 body fluids. Clin Chem, 2010, 56(11): 1733-1741.[8] Zubakov D, Boersma AWM, Choi Y, van Kuijk PF, Wiemer EAC, Kayser M. MicroRNA markers for forensic body fluid identification obtained from microarray screening and quantitative RT-PCR confirmation. Int J Legal Med, 2010, 124(3): 217-226.[9] Hanson EK, Lubenow H, Ballantyne J. Identification of forensically relevant body fluids using a panel of differentially expressed microRNAs. Anal Biochem, 2009, 387(2): 303-314.[10] Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, Mitchell PS, Bennett CF, Pogosova-Agadjanyan EL, Stirewalt DL, Tait JF, Tewari M. Argonaute2 complexes carry a population of circulating microRNAs inde-pendent of vesicles in human plasma. Proc Natl Acad Sci USA, 2011, 108(12): 5003-5008.[11] Hunter MP, Ismail N, Zhang XL, Aguda BD, Lee EJ, Yu LL, Xiao T, Schafer J, Lee ML, Schmittgen TD, Nana- Sinkam SP, Jarijoura D, Marsh CB. Detection of microRNA expression in human peripheral blood microvesi-cles. PLoS One, 2008, 3(11): e3694.[12] Hadi V, Karin E, Apostolos B, Margareta S, James JL, Jan OL. Exosome-mediated transfer of mRNAs and microR-NAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol, 2007, 9(6): 654-659.[13] Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol, 2008, 110(1): 13-21.[14] Zheng D, Haddadin S, Wang Y, Gu LQ, Perry MC, Freter CE, Wang MX. Plasma microRNAs as novel biomarkers for early detection of lung cancer. Int J Clin Exp Pathol, 2011, 4(6): 575-586.[15] Gibbings DJ, Ciaudo C, Erhardt M, Voinnet O. Multive-sicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat Cell Biol, 2009, 11(9): 1143-1149.[16] Etheridge A, Lee I, Hood L, Galas D, Wang K. Extracel-lular microRNA: A new source of biomarkers. Mutat Res, 2011, 717(1-2): 85-90.v[17] Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA, 2008, 105(30): 10513-10518.[18] Park NJ, Zhou H, Elashoff D, Henson BS, Kastratovic DA, Abemayor E, Wong DT. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res, 2009, 15(17): 5473-5477.[19] Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res, 2011, 39(16): 7223-7233.[20] Lodes MJ, Caraballo M, Suciu D, Munro S, Kumar A, Anderson B. Detection of cancer with serum miRNAs on an oligonucleotide microarray. PLoS One, 2009, 4(7): e6229.[21] Kroh EM, Parkin RK, Mitchell PS, Tewari M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods, 2010, 50(4): 298-301.[22] Liu X, Sempere LF, Guo YL, Korc M, Kauppinen S, Freemantle SJ, Dmitrovsky E. Involvement of microRNAs in lung cancer biology and therapy. Transl Res, 2011, 157(4): 200-208.[23] Wang K, Zhang SL, Weber J, Baxter D, Galas DJ. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res, 2010, 38(20): 7248-7259.[24] Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, Banham AH, Pezzella F, Boultwood J, Wain-scoat JS, Hatton CS, Harris AL. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol, 2008, 141(5): 672-675.[25] Minna JD, Roth JA, Gazdar AF. Focus on lung cancer. Cancer Cell, 2002, 1(1): 49-52.[26] Shen J, Todd NW, Zhang H, Yu L, Xing LX, Mei YP, Guarnera M, Liao JP, Chou A, Lu CL, Jiang ZR, Fang HB, Katz RL, Jiang F. Plasma microRNAs as potential bio-markers for non-small-cell lung cancer. Lab Invest, 2011, 91(4): 579-587.[27] Pall GS, Hamilton AJ. Improved northern blot method for enhanced detection of small RNA. Nat Protoc, 2008, 3(6): 1077-1084.[28] Liu CG, Calin GA, Meloon B, Gamliel N, Sevignani C, Ferracin M, Dumitru CD, Shimizu M, Zupo S, Dono M, Alder H, Bullrich F, Negrini M, Croce CM. An oligonu-cleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci USA, 2004, 101(26): 9740-9744.[29] Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ, Guegler KJ. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res, 2005, 33(20): e179.[30] Liu M, Chen HP. The role of microRNAs in colorectal cancer. J Genet Genomics, 2010, 37(6): 347-358.[31] Keller A, Leidinger P, Gislefoss R, Haugen A, Langseth H, Staehler P, Lenhof HP, Meese E. Stable serum miRNA profiles as potential tool for non-invasive lung cancer di-agnosis. RNA Biol, 2011, 8(3): 506-516.[32] Bianchi F, Nicassio F, Marzi M, Belloni E, Dall'olio V, Bernard L, Pelosi G, Maisonneuve P, Veronesi G, Di Fiore PP. A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Mol Med, 2011, 3(8): 495-503.[33] Chen X, Ba Y, Ma LJ, Cai X, Yin Y, Wang KH, Guo JG, Zhang YJ, Chen JN, Guo X, Li Q, Li XY, Wang WJ, Zhang Y, Wang J, Jiang XY, Xiang Y, Xu C, Zheng PP, Zhang JB, Li RQ, Zhang HJ, Shang XB, Gong T, Ning G, Wang J, Zen K, Zhang JF, Zhang CY. Characterization of microRNAs in serum: a novel class of biomarkers for di-agnosis of cancer and other diseases. Cell Res, 2008, 18(10): 997-1006.[34] Jeong HC, Kim EK, Lee JH, Lee JM, Yoo HN, Kim JK. Aberrant expression of let-7a miRNA in the blood of non-small cell lung cancer patients. Mol Med Report, 2011, 4(2): 383-387.[35] Zhu WY, Liu XG, He JY, Chen DD, Hunag YY, Zhang Y. Overexpression of members of the microRNA-183 family is a risk factor for lung cancer: a case control study. BMC Cancer, 2011, 11: 393.[36] Kossenkov AV, Vachani A, Chang C, Nichols C, Billouin S, Horng W, Rom WN, Albelda SM, Showe MK, Showe LC. Resection of non-small cell lung cancers reverses tumor-induced gene expression changes in the peripheral immune system. Clin Cancer Res, 2011, 17(18): 5867-5877.[37] Wang ZX, Bian HB, Wang JR, Cheng ZX, Wang KM, De W. Prognostic significance of serum miRNA-21 expres-sion in human non-small cell lung cancer. J Surg On-col, 2011, 104(7): 847-851.[38] Wei J, Gao W, Zhu CJ, Liu YQ, Mei Z, Cheng T, Shu YQ. Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer. Chin J Cancer, 2011, 30(6): 407-414.[39] Lin QF, Mao WD, Shu YQ, Lin F, Liu SP, Shen H, Gao W, Li SQ, Shen D. A cluster of specified microRNAs in pe-ripheral blood as biomarkers for metastatic non-small-cell lung cancer by stem-loop RT-PCR. J Cancer Res Clin Oncol, 2012, 138(1): 85-93.[40] Roth C, Kasimir-Bauer S, Pantel K, Schwarzenbach H. Screening for circulating nucleic acids and caspase activ-ity in the peripheral blood as potential diagnostic tools in lung cancer. Mol Oncol, 2011, 5(3): 281-291.[41] Boeri M, Verri C, Conte D, Roz L, Modena P, Facchinetti F, Calabrò E, Croce CM, Pastorino U, Sozzi G. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci USA, 2011, 108(9): 3713-3718.[42] Chen X, Hu ZB, Wang WJ, Ba Y, Ma LJ, Zhang CN, Wang C, Ren ZJ, Zhao Y, Wu SJ, Zhuang R, Zhang YX, Hu H, Liu CZ, Xu L, Wang J, Shen HB, Zhang JF, Zen K, Zhang CY. Identification of ten serum microRNAs from a ge-nome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer di-agnosis. Int J Cancer, 2012, 130(7): 1620-1628.[43] Foss KM, Sima C, Ugolini D, Neri M, Allen KE, Weiss GJ. miR-1254 and miR-574-5p: serum-based microRNA bio-markers for early-stage non-small cell lung cancer. J Thorac Oncol, 2011, 6(3): 482-488.[44] Silva J, García V, Zaballos Á, Provencio M, Lombardía L, Almonacid L, García JM, Domínguez G, Peña C, Diaz R, Herrera M, Varela A, Bonilla F. Vesicle-related microR-NAs in plasma of nonsmall cell lung cancer patients and correlation with survival. Eur Respir J, 2011, 37(3): 617-623.[45] Leidinger P, Keller A, Borries A, Huwer H, Rohling M, Huebers J, Lenhof HP, Meese E. Specific peripheral miRNA profiles for distinguishing lung cancer from COPD. Lung Cancer, 2011, 74(1): 41-47.[46] Shen J, Liu ZL, Todd NW, Zhang H, Liao JP, Yu L, Guarnera MA, Li RY, Cai L, Zhan M, Jiang F. Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers. BMC Can-cer, 2011, 11: 374.[47] Xie L, Chen X, Wang LF, Qian XP, Wang TT, Wei J, Yu LX, Ding YT, Zhang CY, Liu BR. Cell-free miRNAs may indicate diagnosis and docetaxel sensitivity of tumor cells in malignant effusions. BMC Cancer, 2010, 10: 591.[48] Yu L, Todd NW, Xing LX, Xie Y, Zhang H, Liu ZQ, Fang HB, Zhang J, Katz RL, Jiang F. Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers. Int J Cancer, 2010, 127(12): 2870-2878.[49] Xing LX, Todd NW, Yu L, Fang BH, Jiang F. Early detec-tion of squamous cell lung cancer in sputum by a panel of microRNA markers. Mod Pathol, 2010, 23(8): 1157-1164.[50] Xie Y, Todd NW, Liu ZQ, Zhan M, Fang HB, Peng H, Alattar M, Deepak J, Stass SA, Jiang F. Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. Lung Cancer, 2010, 67(2): 170-176.[51] Wang Y, Zheng DL, Tan QL, Wang MX, Gu LQ. Nanopore- based detection of circulating microRNAs in lung cancer patients. Nat Nanotechnol, 2011, 6(10): 668-674.[52] Fanini F, Vannini I, Amadori D, Fabbri M. Clinical im-plications of microRNAs in lung cancer. Semin On-col, 2011, 38(6): 776-780.[53] Hennessey PT, Sanford T, Choudhary A, Mydlarz WW, Brown D, Adai AT, Ochs MF, Ahrendt SA, Mambo E, Califano JA. Serum microRNA biomarkers for detection of non-small cell lung cancer. PLoS One, 2012, 7(2): e32307. |
